Drug interactions and side effects of Semaglutide In studying the effects of semaglutide treatment on the pharmacokinetics metformin, warfarin, atorvastatin and digoxin, it was found that this GLP-1 analog did not affect such properties to a clinically relevant degree (Hausner et al., 2017)
GLP-1 receptors are expressed in various cardiovascular tissues, including the sinoatrial node, and direct cardiac effects cannot be excluded
Board Certified in Obstetrics and Gynecology, specializing in Gynecological surgery, volunteering with free clinics and the Red Cross, he has seen the need for different patient options to help with symptom relief of multiple conditions
#Retatrutide #Obesity #WeightManagement #GLP1 #GIP #MetabolicHealth #Type2Diabetes #ClinicalTrials #FDA #Pharmaceuticals #DrugDevelopment #MedicalResearch #HealthcareInnovation #EliLilly #Endocrinology #EvidenceBasedMedicine To view or add a comment, sign in More Relevant Posts 6th DES 2026 Breakthrough News & Updates Oral GLP-1 Pills Are About to Expand Access Orforglipron is an investigational, once-daily oral GLP-1 receptor agonist (non-peptide) under development by Eli Lilly